Join us for an exclusive-scientific conversation with Ali Rıza Akın and Dr. Fred Hızal!
Our guest Ali Rıza Akın will discuss topics such as how your gut microbiome impacts your overall health, how microbiota treat cancer and affect daily health and happiness, among other topics. The program will be hosted by Dr. Fred Hızal.
On Sunday, August 18, 12:00 PM at Türkevi, 3170 De la Cruz Blvd. #119 Santa Clara, CA 95054
Don’t miss this exceptional opportunity to be a part of this enriching, interesting and current scientific conversation! The event will begin with a light breakfast.
Reserve your place today!
CHIEF SCIENTIFIC OFFICER & CO-FOUNDER
He began his scientific career at the University of Istanbul, Biology Department, where he worked on human microbiota, next-generation probiotics, and host-microbe relationships for 25 years. He continued his research journey in Northern California, Silicon Valley. In particular, he led a team that made groundbreaking discoveries of dozens of new-generation bacteria worldwide in the last 10 years. His microbiota studies, especially regarding the impact of bacteria on human health and creative solutions like appetite control with probiotics, have opened up new horizons in his research. Furthermore, he is also among the authors of the book 'Bacterial Therapy of Cancer Written in collaboration with some of the world's leading scientists in the field.
His work in the United States has been carried out in collaboration with research centers such as UCLA, Imperial College of London, University of Manchester, University of Groningen, University College Cork, Bill and Melinda Gates Foundation, and Novartis Biomedical Research Institute. Along with patented inventions in Europe, Japan, and America, he has also filed patents for “Treatment of Metabolic Diseases with Next-Generation Bacteria”.
Ali Rıza AKIN was the first to introduce highly effective products based on systems developed for the Akkermansia and Christensenella families, the most famous among the next-generation probiotics. These products are aimed at controlling hunger hormones, eliminating insulin resistance, weight loss, eliminating stress-depression, and alleviating menstrual pain using new generation prebiotics. They were first introduced in Turkey and were made available through private health insurances in the United States in 2022.
Ali R. Akın's latest project involves creating a product incorporating hundreds of new-generation probiotic strains under the same concept. This project aims to put an end to fecal transplantation in the world. In the 21st century, Ali Rıza Akın is paving new paths in Anaerobic Microbiology studies, opening up exciting new perspectives on human health.
One of the most famous figures in the field of new generation probiotics, Ali R. Akın is currently actively serving as a scientific consultant in California's Silicon Valley and at the next microbiome company.
Alirizakin.com
MANAGER-INNOVATION & DESIGN @STANFORD HEALTH CARE
He is the Manager of Innovation and Design at Stanford Health Care. With over five years of experience in healthcare, Fred leads the development of innovative medical solutions to improve patient care. He holds PhD degrees in Biomedical Engineering and Mechanical Engineering, with expertise in designing and optimizing medical devices and systems.
Fred’s work focuses on creating effective and reliable healthcare technologies. His research on surfaces that interact with bacteria has led to several published papers, highlighting his problem-solving skills and innovative approach. Passionate about improving health outcomes, Fred is dedicated to finding new ways to enhance patient satisfaction and care quality.
As a panel moderator, Fred brings his deep understanding of healthcare innovation and a commitment to exploring the fascinating connections between gut health and mental well-being.